The influence of lifestyle factors on survival following a diagnosis of colorectal cancer (CRC) is not well established. We examined associations between lifestyle factors measured before diagnosis and CRC survival. The Melbourne Collaborative Cohort Study collected data on alcohol intake, cigarette smoking and physical activity, and body measurements at baseline (1990)(1991)(1992)(1993)(1994) and wave 2 (2003-2007). We included participants diagnosed to 31 August 2015 with incident stages I-III CRC within 10-years post exposure assessment. Information on tumor characteristics and vital status was obtained. Tumor DNA was tested for microsatellite instability (MSI) and somatic mutations in oncogenes BRAF (V600E) and KRAS. We estimated hazard ratios (HRs) for associations between lifestyle factors and overall and CRC-specific mortality using Cox regression. Of 724 eligible CRC cases, 339 died (170 from CRC) during follow-up (average 9.0 years). Exercise (non-occupational/leisure-time) was associated with higher CRCspecific survival for stage II (HR 5 0.25, 95% CI: 0.10-0.60) but not stages I/III disease (p for interaction 5 0.01), and possibly for colon and KRAS wild-type tumors. Waist circumference was inversely associated with CRC-specific survival (HR 5 1.25 per 10 cm increment, 95% CI: 1.08-1.44), independent of stage, anatomic site and tumor molecular status. Cigarette smoking was associated with lower overall survival, with suggestive evidence of worse survival for BRAF mutated CRC, but not with CRC-specific survival. Alcohol intake was not associated with survival. Survival did not differ by MSI status. We have identified pre-diagnostic predictors of survival following CRC that may have clinical and public health relevance.
Introduction
Survival following a diagnosis of colorectal cancer (CRC) has improved in recent decades but a substantial proportion of those diagnosed continue to die from CRC, making it important to identify factors associated with survival. 1 Studies of factors associated with disease outcomes have predominantly examined the role of tumor characteristics, with stage at diagnosis being the most important predictor of survival, 2 and have also evaluated potentially modifiable lifestyle factors such as obesity, physical activity and diet. [3] [4] [5] [6] A previous analysis from the Melbourne Collaborative Cohort Study (MCCS) reported that physical activity prior to diagnosis was associated with higher overall and CRC-specific survival for patients diagnosed with stage II or III CRC, while increased central obesity was associated with lower survival. 7 While the role of smoking has been examined widely, [8] [9] [10] [11] [12] [13] [14] more recent studies have assessed alcohol intake. 10, [15] [16] [17] [18] [19] Studies of CRC survival by tumor molecular characteristics have mostly used microsatellite instability (MSI) status. 20 Our study updates and extends a previous analysis of MCCS data by including an additional 11 years of follow-up, additional lifestyle factors including smoking and alcohol intake, and survival by CRC subtype based on MSI status and somatic mutations in the oncogenes BRAF (V600E) and KRAS (codons 12 and 13).
Material and Methods

Study population
The MCCS is an Australian prospective cohort study of 41,513 people (99.2% aged 40-69 years; 58.9% women) recruited during 1990-1994 from Melbourne residents. 21 At study entry (baseline), participants attended clinics where demographic, anthropometric, lifestyle and dietary information was collected and anthropometric measurements performed. Additional information was collected between 2003 and 2007 (wave 2). Participants gave written informed consent to participate and for investigators to obtain access to their medical records. Cancer Council Victoria's Human Research Ethics Committee approved the study protocol.
For this analysis, we selected participants who did not have a previous diagnosis of cancer at enrolment and had an incident CRC diagnosed during follow-up, within 10 years of exposure assessment at baseline or wave 2 (Supplementary Figure S1 ). Individuals with metastatic disease (stage IV) were excluded for greater comparability to previous studies [22] [23] [24] and to minimize potential effects of reverse causation such as undiagnosed advanced disease altering lifestyle patterns before diagnosis. Participants who had a CRC diagnosed <6 months after exposure assessment were also excluded. CRC cases were defined as having a first histopathological diagnosis of adenocarcinoma of the colon or rectum reported to the Victorian Cancer Registry (VCR), coded following the 3rd Revision of the International Classification of Diseases for Oncology (ICD-O-3) as colon (C180, C182-189) or rectum (C199, C209). Carcinomas of the appendix, anus and anal canal (including overlapping lesions of rectum, anus and anal canal), and in-situ lesions were excluded. Participants with metachronous CRC were censored at diagnosis of the second primary CRC, for the CRC-specific survival analysis. Tumor anatomic site, stage and degree of differentiation were obtained from VCR and standardized review of archival tumor tissue by a gastrointestinal histopathologist (CR).
Assessment of demographic information, alcohol intake, smoking and physical activity Structured interview schedules were used at baseline to obtain demographic information, and at both waves to collect information about alcohol intake, smoking and physical activity. 21 At baseline, participants were asked whether they smoked at least seven cigarettes a week, and if so, the number of cigarettes they smoked per day and the duration of smoking. At wave 2, smokers at baseline were asked if they were still smoking, and if so the amount smoked. Alcohol intake for non-abstainers was recorded as frequency and quantity of intake per drinking occasion, for beer, wine and spirits, for decades of age starting from 20 years. Detailed information on the method of calculating lifetime intake (g/day) at baseline has been reported previously; 25 at wave 2, intake during
What's new? While survival following colorectal cancer (CRC) is improving, it remains unclear whether increasing survival is linked to specific health or lifestyle factors that were present before or after CRC diagnosis. In our study, based on data from the Melbourne Collaborative Cohort Study (MCCS), exercise prior to diagnosis was associated with higher CRC-specific survival specifically for stage II patients. Waist circumference, by contrast, was associated with reduced CRC-specific survival, while cigarette smoking was associated with lower overall survival. Cigarette smoking was also weakly linked to decreased survival in BRAF-mutated CRC. No associations were detected between CRC survival and alcohol intake.
the previous year was assessed similarly. Physical activity at baseline was assessed by three separate questions obtained from the Risk Factor Prevalence Study conducted by the National Heart Foundation and Australian Institute of Health 26, 27 regarding frequency of non-occupational vigorous and moderate physical activity, and walking, as described by Haydon et al. 7 Those who answered "not at all" to vigorous and moderate physical activity were classified as "nonexercisers" while those who reported any regular exercise (1 time per week) were classified as "exercisers." Individuals were classified as "walkers" if they walked for recreation and/ or exercise at least once a week over the last 6 months, while individuals were classified as "non-walkers" if they answered "not at all" to the question on walking. Additionally, the responses to each question were coded as 0 ("none"), 1.5 (1-2 per week) and 4 (3 per week) and scores for walking and moderate exercise added together along with two times the score for vigorous exercise to generate a physical activity score for each participant, reflecting relative energy expenditure of different activity types. 28 This score was grouped based on approximate quartiles for the MCCS. A modified form of the long version of the International Physical Activity Questionnaire (available at www.ipaq.ki.se) was used at wave 2. 29 It includes questions about duration and frequency of vigorous and moderate physical activity, and walking. We applied the data reduction methods used for baseline data to the wave 2 physical activity data.
Assessment of body composition
Height was measured at baseline to 1 mm with a stadiometer. At both baseline and wave 2, weight was measured to 100 g using digital electronic scales and waist circumferences to 1 mm using a two-meter metal anthropometric tape. 30 
Tumor characterization
The American Joint Committee on Cancer (AJCC) staging system was used to categorize stages: stage I (T 1-2 , N 0 , M 0 ), stage II (T [3] [4] , N 0 , M 0 ) and stage III (T any , N 1-2 , M 0 ). The tumor with the highest stage was used when synchronous CRCs were present. The degree of tumor differentiation was classified as "well," "moderately" and "poorly" differentiated. Separate categories were used for cases with missing stage and degree of differentiation. For tumors diagnosed by June 2009, we attempted to obtain archival tumor tissue and to test tumor DNA for the V600E mutation in BRAF, which accounts for approximately 90% of BRAF mutations in colorectal cancer, 31 using a fluorescent allele-specific PCR discrimination method as previously described 32 and for mutations in exon 2 of KRAS by direct Sanger sequencing. 33 MSI was examined using 10 microsatellite markers. 34 
Ascertainment of deaths and cause of death
Vital status was ascertained through the VCR and the National Death Index (NDI). Cause of death was assigned as reported in the NDI and VCR.
Statistical analysis
We used Cox regression 35 with time since CRC diagnosis as the time axis to estimate hazard ratios (HR) and 95% confidence intervals (CI) for overall and CRC-specific mortality. Analysis time began at date of diagnosis and ended at death or 31 August 2015 (the date at which ascertainment of deaths was complete), whichever came first. For CRC-specific survival, individuals were censored at death when the cause of death was anything other than CRC, but were excluded when no information was available on cause of death. 36 and waist circumference (continuous: per 10 cm; categorical: healthy <94 cm for males, <80 cm for females; action levels 94 cm for males, 80 cm for females). 37 Baseline exposure data were used for participants diagnosed with CRC within 10 years post study enrolment whereas wave 2 exposure data were used for particpants diagnosed with CRC within 10 years post wave 2. All multivariate models were adjusted for age at diagnosis of CRC (categorical: <60, 60-69, 70 years), year of diagnosis (categorical: <1999, 1999-2005, 2006), sex and the country of birth (Australia/United Kingdom, Italy/Greece). We repeated the analyses adjusting additionally for AJCC stage (categorical: stage I, stage II, stage III), degree of differentiation (categorical: well/moderately, poorly differentiated) and anatomic site (colon, rectum), potential mediators of associations between the lifestyle factors and survival following CRC. A sensitivity analysis performed to account for potential effects of reverse causation excluded participants with pre-existing diagnosis of heart attack, stroke, angina or diabetes. A subgroup analysis was performed to test differences in associations by MSI (MSI-low/MSS, MSI-high), BRAF and KRAS status. We fitted interaction terms to test for differences in HRs for each lifestyle factor by stage, site and molecular status. We compared nested models using the likelihood ratio test. We examined each model for outliers and influential points and used Schoenfeld residuals to assess the proportional hazard assumptions; there was no evidence that they were violated. All statistical analyses were performed using Stata 14.1 (StataCorp, College Station, TX).
Results
Among eligible MCCS participants with no previous diagnosis of cancer at enrolment, 1,227 incident CRC cases were Cancer Epidemiology Figure S2) . The median time from exposure measurement to CRC diagnosis was 4.9 years (interquartile range 5 2.9-7.0 years), and the average follow-up from CRC diagnosis was 9.0 years. During follow-up, 339 deaths occurred, of which 170 (50%) were CRC-specific; cause of death was unknown for 26 while 23 participants were censored at diagnosis of the second primary CRC for the CRC-specific survival analysis. Characteristics of participants included in the analysis are shown in Table 1 . Participants with unknown tumor molecular data did not differ from others in terms of age, sex or ethnicity (data not shown). The proportion missing tumor molecular data was higher for those with an action level waist circumference compared to those with a healthy waist circumference (Table 1) . HR estimates for overall and CRC-specific mortality are shown in Table 2 and Table 3 , respectively. Lifetime, current and past alcohol intakes were not associated with survival; HR for current wine intake with CRC-specific survival was 0.86 (95% CI: 0.75-1.00) (data not shown). Cigarette smoking was not associated with CRC-specific survival although lower CRC-specific survival was evident for former smokers who quit 10 years ago (HR 5 1.92, 95% CI: 1.04-3.55). A dose-dependent association between smoking and overall survival was observed (p for trend 5 0.04 for number of cigarettes smoked per day). Higher waist circumference was associated with lower overall and CRC-specific survival (e.g. HR 5 1.25 per 10 cm increment, 95% CI: 1.08-1.44 for CRCspecific survival); the association for BMI with survival was less clear (HR 5 1.18 per 5 kg/m 2 increment, 95% CI: 0.98-1.42 for CRC-specific survival). Measures of physical activity were not associated with survival in this analysis. These associations did not materially change when adjusted for primary CRC-related features (stage, degree of differentiation, site), or when participants with pre-existing disease were excluded (Supplementary Table S1 ).
Exercise prior to diagnosis was associated with higher CRC-specific survival for those diagnosed with stage II (HR 5 0.25, 95% CI: 0.10-0.60) but not with stage I or III CRC (p for interaction 5 0.01) ( Table 4 ; additional results in Supplementary Table S2 ). The corresponding HR for those diagnosed with stage II CRC with overall survival was 0.60 (95% CI: 0.40-0.90) ( Table 4 ). There was also suggestive evidence that the higher disease-specific survival in relation to exercise prior to diagnosis was limited to colon cancer (HR 5 0.68, 95% CI: 0.44-1.05; p for interaction 5 0.09) ( Table 5 ) and to KRAS wild-type CRC (HR 5 0.61, 95% CI: 0.38-0.98; p for interaction 5 0.1) ( Fig. 1; Supplementary  Table S4 ). These associations were stronger after adjustment for primary CRC-related features (Supplementary Tables S3  and S5 ). Differential survival observed for walking (lowest overall survival observed for stage III: HR 5 1.84, 95% CI: 1.10-3.08; p for interaction 5 0.01) was not evident when participants with existing illnesses were excluded (p for interaction 5 0.2); excluding participants with existing illnesses did not change results for exercise (HR 5 0.22, 95% CI: 0.08-0.57 for stage II CRC; p for interaction 5 0.002 for CRCspecific survival) (data not shown).
There was weak evidence of approximately a twofold lower survival for smokers with BRAF mutated CRC Table S4 ). There were no differences in survival for lifestyle factors by MSI status (data not shown).
Discussion
While lower CRC-specific survival was observed for individuals who were obese prior to CRC diagnosis, exercise was only associated with higher disease-specific survival for stage II disease, and possibly, colon cancer and KRAS wild-type tumors. Although cigarette smoking prior to CRC diagnosis was associated with lower overall survival with suggestive evidence of worse survival for BRAF mutated CRC, smoking was not associated with CRC-specific survival. Pre diagnosis alcohol intake was not related to survival. Smoking, a known risk factor 38 especially for BRAF mutated and MSI-high CRC incidence, 39 is a strong determinant of mortality. 40 The absence of an association with CRCspecific survival in our study contrasts with evidence from the North Central Cancer Treatment Group Phase III Trial N0147 which found adverse disease-free survival for smoking 4 Includes only former smokers. 5 People who only reported exercising were excluded. 6 Waist circumference categorized as healthy (<94 cm for males; <80 cm for females) and action levels (94 cm for males; 80 cm for females). 
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for BRAF wild-type and KRAS mutated colon cancer. 14 However, the definition of survival outcome was different (time to colon cancer recurrence or death from any cause) and the study included only participants with stage III colon cancer. 14 Using the same cohort of clinical trial participants, authors observed a potentially beneficial effect on survival from wine intake with no association for drinking overall. 16 The absence of an association between lifetime alcohol intake and survival in our study is consistent with existing evidence for alcohol. 10, 15, 17 Long-term alcohol intake is associated with a 50% higher risk of CRC, 41 but evidence for differential risks by anatomic location [42] [43] [44] or by molecular subtype (MSI; [45] [46] [47] [48] [49] BRAF and CIMP 50, 51 ) has been inconsistent. Authors of a recent analysis of a large population-based German cohort discussed the possible contamination of abstainers with "sick quitters"
52 as a possible explanation for lower CRC-specific survival seen for abstainers among nonmetastatic CRC patients with current as well as lifetime intake; 19 Rehm et al.
have shown that using lifetime abstention as the reference category may not completely avoid contamination. 53 We Table 3 . Hazard ratios (HR) and 95% confidence intervals (CI) for CRC-specific mortality by alcohol intake, cigarette smoking, physical activity, exercise, walking, BMI and waist circumference (Continued) P for trend 0.08 0.02 1 Adjusted for age at diagnosis, year of diagnosis, sex and country of birth in addition to the exposures shown in the table; current alcohol intake (continuous) additionally adjusted for former drinking (yes; no). 2 Adjusted for age at diagnosis, year of diagnosis, sex, country of birth, American Joint Committee on Cancer stage, degree of differentiation and anatomic site in addition to the exposures shown in the table; current alcohol intake (continuous) additionally adjusted for former drinking (yes; no). 3 Calculated excluding former drinkers. 4 Includes only former smokers. 5 People who only reported exercising were excluded. 6 Waist circumference categorized as healthy (<94 cm for males; <80 cm for females) and action levels (94 cm for males; 80 cm for females). 
have been able to differentiate former drinkers from abstainers in our study. Our findings for obesity and exercise are biologically plausible and replicate existing evidence 6, 13, [22] [23] [24] 54, 55 considering the inverse relationship between the two. Among the postulated biological explanations for an association between obesity and survival following CRC are increased insulin resistance, 3 inflammation and oxidative stress, and impaired immune surveillance, 56 factors which might also be related to CRC incidence. On the other hand, physical activity favorably affects survival following CRC via increased insulin-like growth factor binding proteins, 3, 57 and by modulating oxidative DNA damage. 58 We replicated our previous findings for a detrimental association between obesity and survival following CRC that is more evident with waist circumference than with BMI, and for differential associations with exercise, which most likely differentiated those who were physically active from those who were not in our data, by disease stage. 7 A greater benefit in terms of CRC-specific survival relative to overall survival for those diagnosed with stage II CRC in our study is consistent with previous evidence that attributed higher survival associated with exercise following a cancer diagnosis to a reduction in cancer deaths and not primarily to a reduction in cardiovascular deaths. 22, 59 A direct effect of physical activity on tumor biology could potentially be mediated via a number of mechanisms. For example, physical activity may interact with insulin-like growth factor binding protein 3, 57 which can inhibit growth via the transforming growth factor b pathway 60 and can also induce apoptosis. 61 Contrary to others, we did not observe differential survival for obesity by disease stage. 5, 54 We speculate that evidence of differential survival by disease stage for walking status that diminished when participants with existing illness were excluded may have been due to reverse causation. We cannot, however, rule out unmeasured potential confounders and chance (especially considering the multiple hypotheses tested) as explanations for our results.
Our finding suggestive of a greater survival benefit from exercise for colon but not rectal cancer is in line with findings from the Seattle Colon Cancer Family Registry, 22 and may reflect a greater diagnostic delay and symptomatic disease at the time of diagnosis for rectal cancer. 62 Existing evidence for differential survival by anatomic site for obesity is inconsistent, 5,55,63 and we did not observe any. Few findings have been reported for subtypes defined by somatic mutations in oncogenes. Evidence of an association between obesity and the risk of BRAF mutated or CIMP1 CRC (which is highly correlated with somatic mutations in BRAF) is inconsistent. 64, 65 It is possible that we may not have observed lower survival associated with obesity for BRAF mutated CRC in our study due to the exclusion of stage IV tumors (stage IV tumors and BRAF mutated CRC have lower survival 66 ). We observed weak evidence suggestive of a survival benefit of exercise that was limited to KRAS wild-type CRC. The only comparable study that has considered subtypes based on BRAF and KRAS status did not observe evidence of differential survival. 22 BRAF and KRAS are routinely assessed for screening for Lynch syndrome and for assessing response to therapy, respectively, 67, 68 and any potential survival benefit for KRAS wild-type CRC could have important clinical implications.
Strengths of this analysis include: prospective design; near complete follow-up; relatively large number of deaths and availability of detailed information on lifestyle factors. Our study also contributes to a sparse literature by examining the relationship between alcohol intake and survival following CRC 10 and by evaluating survival by BRAF and KRAS status: 14, 22 the etiology of each CRC is unique [69] [70] [71] There are several limitations. First, the unavailability of full details of treatment has prevented the evaluation of treatment as an effect modifier. Disease stage is highly correlated with treatment but does not completely alleviate this limitation. Second, we addressed the issue of reverse causation by excluding individuals with metastatic disease or with a CRC diagnosis <6 months after exposure assessment. Individuals with pre-existing illness prior to CRC diagnosis were also excluded in a sensitivity analysis. Ill health altering lifestyle patterns before CRC, however, cannot be excluded completely. Third, we measured alcohol intake, cigarette smoking, physical activity and body size prior to the diagnosis of CRC. Lifestyle habits and body size could have changed during the period from exposure ascertainment to CRC diagnosis, and also after cancer diagnosis. To minimize effects of changes in lifestyle habits and body size during follow up, we limited the analysis to CRC diagnosed within 10 years of exposure ascertainment. Fourth, measurement error and misclassification of alcohol intake, and unmeasured potential confounding and inaccuracy of self-reported physical activity measurement may have influenced estimates of association. Fifth, archival tissue from the CRC was unavailable for a substantial number of cases, with slightly more missing for those with an action level compared to a healthy waist circumference. This may not have biased the observed associations by BRAF and KRAS status as cases with and without tumor molecular data varied little by demographic characteristics such as ethnicity and sex which were both strongly associated with molecular subtype. Nonetheless, wide CIs were sometimes observed in our results for tumor molecular subtypes. Finally, misclassification of underlying cause of death is also possible.
In conclusion, smoking, exercise and obesity are not only risk factors for CRC, but are also associated with survival after diagnosis. Future research is necessary to determine whether exercising, losing weight and smoking cessation after CRC diagnosis affect survival, and to examine underlying molecular pathological mechanisms underpinning these associations.
